Search Results for: compassionate use

8 simple reasons not to get an unlicensed stem cell treatment part 2: lack of follow-up

I’m doing a series of posts on straightforward reasons why patients should not get unlicensed stem cell treatments. Part 1 of the series was on the risk of losing medical insurance coverage. Today is part 2, which is focused on a serious failing of many for-profit, point-of-care stem cell clinics selling unlicensed treatments: lack of …

8 simple reasons not to get an unlicensed stem cell treatment part 2: lack of follow-up Read More »

Money and stem cell ‘miracles’: Pluristem questioned on ethics

Pluristem Therapeutics Inc. is a publicly traded (NASDAQ) biotech Israeli company that is developing stem cell treatments based on the use of expanded placental stem cells called PLX cells. The Pluristem PLX drug is not approved for treating patients at this time in any country, however Pluristem has treated a handful of patients via something …

Money and stem cell ‘miracles’: Pluristem questioned on ethics Read More »

Some thoughts on taking risks in science & medicine

taking-risks-e1513621401309

Are you a risk-taker or do you do everything possible to avoid risks? Taking risks in science is necessary, but is there a wise way to take the risks you do? Science and medicine need a certain amount of risk and risk-takers to make transformative leaps forward. The risks in biomedical science can be conceptual …

Some thoughts on taking risks in science & medicine Read More »

Upcoming Right-To-Try debate: NYU’s Roxland and Goldwater’s Sandefur

Right-To-Try-Debate-Roxland-Sandefur

Should patients have the Right To Try experimental therapies that could be unsafe and ineffective? What if those patients have a terminal illness and no reasonable prospects of being helpful to conventional medicine? Doesn’t it make perfect sense to let them try a risky approach if they want to do so? On the other hand, …

Upcoming Right-To-Try debate: NYU’s Roxland and Goldwater’s Sandefur Read More »

Reviews of my new book GMO Sapiens on #CRISPR & human modification

GMO-Sapiens-Book-Cover

It’s exciting that the reviews are starting to come in on my new book, GMO Sapiens, on human genetic modification including CRISPR. Here is one from The Scientist and the book was recommended by Scientific American. Reviews from individual authors and scientists are below. “GMO Sapiens could not be more timely. New technologies like CRISPR-Cas9 gene …

Reviews of my new book GMO Sapiens on #CRISPR & human modification Read More »

STAP News From Harvard? Vacanti Stepping Down as Chair & Going on Sabbatical

Obokata_Vacanti

What’s the deal with Brigham and Women’s Hospital or Harvard Medical School, where STAP cell senior author works, when it comes to the retracted STAP cell papers? I was just writing yesterday in part about how we haven’t really heard anything (news, statements, etc.) from those places about the whole STAP cell mess. In contrast, in Japan …

STAP News From Harvard? Vacanti Stepping Down as Chair & Going on Sabbatical Read More »